Ameriprise Financial, Inc.
Ameriprise Financial, Inc. (A4S.DE) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Ameriprise Financial, Inc. (A4S.DE), covering cash flow, earnings, and balance sheets.
Ameriprise Financial, Inc. (A4S.DE) Income Statement & Financial Overview
View the income breakdown for Ameriprise Financial, Inc. A4S.DE across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.50B | $4.40B | $4.22B | $4.15B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $4.50B | $4.40B | $4.22B | $4.15B |
| Gross Profit Ratio | $1.00 | $0.47 | $0.53 | $0.59 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.63B | $2.51B | $2.41B | $2.38B |
| Operating Expenses | $3.15B | $3.75B | $3.17B | $2.93B |
| Total Costs & Expenses | $3.15B | $3.75B | $3.17B | $2.93B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $77.00M | $87.00M | $83.00M | $82.00M |
| Depreciation & Amortization | -$34.00M | -$36.00M | -$47.00M | -$42.00M |
| EBITDA | $1.32B | $609.00M | $1.004B | $1.18B |
| EBITDA Ratio | $0.21 | $0.18 | $0.25 | $0.38 |
| Operating Income | $1.35B | $645.00M | $1.05B | $1.22B |
| Operating Income Ratio | $0.21 | $0.00 | $0.26 | $0.37 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $1.35B | $645.00M | $1.05B | $1.22B |
| Income Before Tax Ratio | $0.24 | $0.16 | $0.24 | $0.28 |
| Income Tax Expense | $281.00M | $134.00M | $222.00M | $229.00M |
| Net Income | $1.07B | $511.00M | $829.00M | $990.00M |
| Net Income Ratio | $0.24 | $0.13 | $0.19 | $0.23 |
| EPS | $10.80 | $5.09 | $8.16 | $9.63 |
| Diluted EPS | $10.58 | $5.00 | $8.02 | $9.46 |
| Weighted Avg Shares Outstanding | $99.20M | $100.40M | $101.60M | $102.80M |
| Weighted Avg Shares Outstanding (Diluted) | $101.20M | $102.20M | $103.40M | $104.60M |
The company's financials show resilient growth, with revenue advancing from $4.15B in Q1 2024 to $4.50B in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to 59% in Q1 2024. Operating income hit $1.35B last quarter, sustaining a consistent 21% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.32B. Net income rose to $1.07B, while earnings per share reached $10.80. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan